The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

6776–6800 of 18015

  • ModerateFDA (Drugs)·D-0651-2020·2020-01-15

    Enovachem Recalls Estriol USP Micronized Due to Impurity Test Failures

    Asclemed USA Inc. dba Enovachem Pharmaceuticals is recalling specific lots of Estriol, USP, (Micronized), 0.12 g, because additional testing found Out of Specification impurity test results.

    Product
    Estriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-37
    Category
    Drug
    Distribution
    1 state
  • LowFDA (Drugs)·D-0784-2020·2020-01-15

    Idelle Labs Recalls SURE Antiperspirant for Undeclared Active Ingredient

    Idelle Labs is recalling SURE 48hr Confidence Nourishing Coconut Antiperspirant & Deodorant because the label lists an active ingredient that is not actually in the product.

    Product
    SURE 48hr Confidence Nourishing Coconut invisible solid Antiperspirant & Deodorant Net Wt 2.6 oz (73g) NDC# 41595-5547-1 UPC 8 83484 31020 5 Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0633-2020·2020-01-08

    FDA Recalls Silver Bullet Male Enhancement Capsules for Undeclared Active Ingredient

    The FDA is recalling Silver Bullet male enhancement capsules because they contain an undeclared active ingredient (Sildenafil) and were marketed without an approved NDA/ANDA.

    Product
    Silver Bullet, Get Bigger and Harder, Works in Minutes, Lasts for Days, 10 male enhancement capsules in blister foil package, 725mg per capsule, Distributed by Silver Bullet Ltd, Golden Springs, CO, USA, UPC: 610877392698.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0631-2020·2020-01-08

    American Health Packaging Recalls Ranitidine Syrup Due to NDMA Impurity

    American Health Packaging is recalling specific lots of Ranitidine Syrup because the presence of the NDMA impurity was detected in the product.

    Product
    Ranitidine Syrup (Ranitidine Oral Solution USP), 15 mg/mL, 150 mg/10 mL per cup, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio. (a) Case of 50 cups (NDC 60687-260-69) (b) Case of 40 cups (NDC 60687-260-23 (c) Unit Dose Cup (NDC 60687-260-69)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0632-2020·2020-01-08

    Ranitidine Tablets Recalled Due to NDMA Impurity

    Granules India Limited is recalling Ranitidine tablets because the active ingredient contained the impurity N-nitrosodimethylamine (NDMA).

    Product
    RANITIDINE — RANITIDINE (RANITIDINE)
    Category
    Drug
    Distribution
    3 states
  • ModerateFDA (Drugs)·D-0647-2020·2020-01-08

    Akorn Recalls Myorisan 20mg Capsules Due to Mispackaging Error

    Akorn, Inc. is recalling Myorisan (isotretinoin) 20mg capsules because some cartons contained 40mg blister cards. The error was found in a customer complaint.

    Product
    MYORISAN (isotretinoin capsules, USP), 20mg, packaged in 30-count Capsules (3 x 10 Prescription Packs) per box, Rx only, Distributed by: VersaPharm Inc. - An Akorn Company, Lake Forset, IL 60045; NDC 61748-302-13.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0635-2020·2020-01-08

    Lupin Recalls Bimatoprost Ophthalmic Solution Due to Impurity Specifications

    Lupin Pharmaceuticals is recalling 2,130 bottles of Bimatoprost Ophthalmic Solution because an out-of-specification impurity was detected.

    Product
    Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0634-2020·2020-01-08

    PCA Skin Blemish Control Bar Recalled for High Salicylic Acid Content

    Island Kinetics is recalling PCA Skin Blemish Control Bar because the salicylic acid content exceeds the firm's specifications.

    Product
    PCA Skin Blemish Control Bar, 3.2 oz/90g, Salicylic acid 2% - Acne cleanser, For external use only, Distributed by PCA Skin, 6210 E. Thomas Rd., Ste. 200, Scottsdale, AZ 85251; UPC 812025010397.
    Category
    Drug
    Distribution
    1 state
  • ModerateFDA (Drugs)·D-0628-2020·2020-01-01

    Spectrum Laboratory Products Recalls Subpotent Estriol Micronized USP

    Spectrum Laboratory Products is recalling specific lots of Estriol Micronized USP because assay results did not meet specifications.

    Product
    Estriol [(16a, 17B)-Estra-1,3,5(10)-triene-3,16,17-triol; Oestriol] Micronized, USP, CAS 50-27-1, packaged in a) 1 G glass bottles, b) 5 G glass bottles, c) 25 G glass bottles, d) 100 G glass bottles, e) 500 G glass bottles, and f) 1 KG plastic bottles, Rx Only, Spectrum Chemical
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0625-2020·2020-01-01

    Pharmedium Recalls Subpotent Repinephrine Bitartrate Injection Bags

    Pharmedium Services LLC is voluntarily recalling 5,820 bags of subpotent repinephrine bitartrate injection. The FDA classified this as a Class III recall.

    Product
    NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00 mL Viaflex Bag, High Alert, Rx Only, PharMEDium Services LLC., 12620 W Airport Blvd #130 Sugar Land, TX 77478.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0627-2020·2020-01-01

    Pharmedium Recalls Subpotent Repinephrine Bitartrate Injection Bags

    Pharmedium Services LLC is recalling 5,808 bags of Repinephrine Bitartrate Injection due to subpotent drug levels. The FDA classified this as a Class III recall.

    Product
    NORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 254.00 mL Viaflex Bag, High Alert, Rx Only, PharMEDium Services LLC., 12620 W Airport Blvd #130 Sugar Land, TX 77478.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0626-2020·2020-01-01

    Pharmedium Recalls Subpotent Repinephrine Bitartrate Injection Bags Nationwide

    Pharmedium Services LLC is voluntarily recalling 864 bags of repinephrine bitartrate injection because the drug was subpotent. The recall covers nationwide distribution in the U.S.

    Product
    NORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 508.00 mL Viaflex Bag, High Alert, Rx Only, PharMEDium Services LLC., 12620 W Airport Blvd #130 Sugar Land, TX 77478.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0630-2020·2019-12-25

    Lannett Recalls Levetiracetam Oral Solution Due to Microbial Contamination

    Lannett Company is recalling specific lots of Levetiracetam Oral Solution because testing found out-of-specification microbial counts.

    Product
    Levetiracetam Oral Solution 100mg/mL, 473 mL (16 fl. oz.) Bottles, Rx Only, Distributed by: Lannett Company, Inc. Philadelphia, PA 19136, NDC 54838-0548-80
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0622-2020·2019-12-25

    Medisca Recalls Estriol USP Micronized Due to Failed Impurity Specifications

    Medisca, Inc. is recalling specific lots of Estriol, USP (Micronized) because the product failed impurities and degradation specifications.

    Product
    Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packed by Medisca Inc., Plattsburgh, NY 12901, USA
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0653-2020·2019-12-25

    AuroMedics Recalls Gabapentin Capsules Due to Foreign Tablet Presence

    AuroMedics Pharma LLC is recalling specific lots of Gabapentin Capsules because a Losartan/HCTZ tablet was found in the bottles.

    Product
    Gabapentin Capsules, USP 100 mg, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65682-198-99
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0629-2020·2019-12-25

    Lupin Recalls Memantine Hydrochloride Capsules Due to Dissolution Failure

    Lupin Pharmaceuticals is recalling 3,726 bottles of Memantine Hydrochloride Extended-release Capsules because stability studies showed high out-of-specification dissolution results.

    Product
    MEMANTINE HYDROCHLORIDE — MEMANTINE HYDROCHLORIDE (MEMANTINE HYDROCHLORIDE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0623-2020·2019-12-25

    Apothecus Recalls VCF Vaginal Contraceptive Foam Due to Canister Leakage

    Apothecus Pharmaceutical Corp. is recalling VCF Vaginal Contraceptive Foam cans and case packs because the canister units exhibit propellant leakage, rendering the product unusable.

    Product
    VCF Vaginal Contraceptive Foam, a) can, 13 applications per can, Net wt. 0.6 oz (17g). NDC 52925-312-14, b) case pack with 36 cans in a nested container. Net wt 0.6 oz (17g) per can. NDC 52925-312-06, Distributed By: Apothecus Pharmaceutical Corp. Oyster Bay, NY 11771.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0611-2020·2019-12-18

    Surgery Pharmacy Services Recalls Trisodium Citrate CRRT Solution for Sterility Concerns

    Surgery Pharmacy Services is recalling 84 bags of Trisodium Citrate 0.5% CRRT Solution due to a lack of sterility assurance. The product was distributed in Georgia and Tennessee.

    Product
    Trisodium Citrate 0.5% CRRT SOLUTION. RX Only. Rx # specific and Patient Specific volumes. Mixed by Surgery Pharmacy Services,3908 TENN.AVE. CHATT,TN37409
    Category
    Drug
    Distribution
    2 states
  • SevereFDA (Drugs)·D-0612-2020·2019-12-18

    Amneal Recalls Ranitidine Tablets Due to NDMA Impurity

    Amneal Pharmaceuticals is recalling Ranitidine Tablets 150 mg because the active ingredient contained the impurity N-nitrosodimethylamine (NDMA).

    Product
    Ranitidine Tablets, USP 150 mg a).60-count bottles (NDC 65162-253-06) , b).100-count bottles (NDC 65162-253-10), c).180-count bottles (NDC 65162-253-18), d).500-count bottles (NDC 65162-253-50) and e)1000-count bottles (NDC 65162-253-11).
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0637-2020·2019-12-18

    AuroMedics Recalls Mirtazapine Tablets Due to Labeling Error

    AuroMedics Pharma LLC is recalling Mirtazapine 15 mg tablets that were incorrectly labeled as 7.5 mg. The error affects 500-count bottles distributed nationwide.

    Product
    MIRTAZAPINE — MIRTAZAPINE (MIRTAZAPINE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0587-2020·2019-12-18

    Anazao Health Recalls Fentanyl and Morphine Compounded Drugs Due to Fungal Contamination

    Anazao Health is recalling compounded fentanyl and morphine drugs after environmental sampling detected Talaromyces rotundus fungi.

    Product
    Fentanyl Citrate and Bupivacaine HCl and Morphine Sulfate in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0614-2020·2019-12-18

    Amneal Recalls Ranitidine Syrup Due to NDMA Impurity

    Amneal Pharmaceuticals is recalling Ranitidine Syrup Oral Solution because the active ingredient contained the impurity N-nitrosodimethylamine (NDMA).

    Product
    Ranitidine Syrup Oral Solution 15 mg/mL 6. fl. oz. (473 mL), NDC 65162-664-90.
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0608-2020·2019-12-18

    FDA Recalls Anazao Health Hydromorphone, Clonidine, and Fentanyl Combination Drugs

    Anazao Health is recalling specific lots of hydromorphone, clonidine, and fentanyl combination drugs due to fungal contamination found during environmental sampling.

    Product
    Hydromorphone HCL and Clonidine HCL and Fentanyl Citrate in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0576-2020·2019-12-18

    Jubilant Cadista Recalls Amantadine Hydrochloride Tablets Due to Foreign Object

    Jubilant Cadista Pharmaceuticals is recalling 1,824 bottles of Amantadine Hydrochloride Tablets because a foreign object was found in a single tablet.

    Product
    Amantadine Hydrochloride Tablets, 100 mg, 100-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee-247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA; NDC 59746-699-01.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0598-2020·2019-12-18

    Anazao Health Recalls Compounded Clonidine Syringes Due to Fungal Contamination

    Anazao Health is recalling compounded Clonidine, Prialt, and Bupivacaine syringes because environmental sampling detected Talaromyces rotundus, a fungus.

    Product
    Clonidine HCL PF 750 mcg/mL/Prialt PF (vial) 55 mcg/mL/Bupivacaine HCL PF 24 mg/mL *Compounded 20 mL Syringe (Standard) AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634 (800) 995-4363
    Category
    Drug
    Distribution
    Distributed nationwide